A new in silico approach to investigate molecular aspects of factor IX missense causative mutations and their impact on the hemophilia B severity

Human Mutation
Mariana R MeirelesGustavo F Vieira

Abstract

Factor IX (encoded by F9) is a protein in the coagulation process, where its lack or deficiency leads to hemophilia B. This condition has been much less studied than hemophilia A, especially in Latin America. We analyzed the structural and functional impact of 54 missense mutations (18 reported by us previously, and 36 other mutations from the Factor IX database) through molecular modeling approaches. To accomplish this task, we examine the electrostatic patterns, hydrophobicity/hydrophilicity, disulfide, and H-bond differences of the Factor IX structures harboring the missense mutations found, correlating them with their clinical effects. The 54 mutated sequences were modeled and their physicochemical features were determined and used as input in clusterization tools. The electrostatic pattern seems to influence in disease severity, especially for mutations investigated in epidermal growth factors 1 and 2 (EGF1/2) domains. The combined use of all physicochemical information improved the clustering of structures associated to similar phenotypes, especially for mutations from GLA and EGF1-2 domains. The effect of mutations in the disease phenotype severity seems to be a complex interplay of molecular features, each one contribut...Continue Reading

References

Jan 1, 1995·Human Mutation·K WulffF H Herrmann
Jan 20, 1998·Trends in Biochemical Sciences·R A LaskowskiJ M Thornton
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jan 30, 2003·Trends in Cardiovascular Medicine·Amy E Schmidt, S Paul Bajaj
Aug 28, 2003·Journal of Thrombosis and Haemostasis : JTH·G JayandharanA Srivastava
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Oct 14, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·S SchulmanR Wallensten
Dec 1, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·M S EnayatF G H Hill
Apr 6, 2006·Bioinformatics·Ryota Suzuki, Hidetoshi Shimodaira
Apr 19, 2008·Nucleic Acids Research·Stefan RichterRebecca C Wade
Mar 6, 2009·Journal of Pediatric Hematology/oncology·Leera QuadrosShrimati Shetty
Dec 2, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·H ElmahmoudiE Gouider
Nov 23, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·C H MillerUNKNOWN Hemophilia Inhibitor Research Study Investigators
Apr 27, 2013·Nucleic Acids Research·Liam J McGuffinDaniel B Roche
May 8, 2015·Nature Protocols·Lawrence A KelleyMichael J E Sternberg
Jul 5, 2015·Molecular Immunology·Marcus F A MendesGustavo F Vieira
Jul 20, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·M R MeirelesE Bandinelli

❮ Previous
Next ❯

Citations

Nov 2, 2020·Biotechnology Letters·Aline Sousa BomfimElisa Maria Sousa Russo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Xue-wen JiangZhuang Liu
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Denise Menezes BrunettaJosé Huygens Parente Garcia
© 2022 Meta ULC. All rights reserved